Off-the-Shelf CAR t cells show promise for Hard-to-Treat myeloma

NCT ID NCT04093596

First seen May 14, 2026 · Last updated May 16, 2026 · Updated 1 time

Summary

This early-phase study tested a new type of CAR T cell therapy, called ALLO-715, in 73 adults with multiple myeloma that had returned or stopped responding to at least three prior treatments. Unlike standard CAR T cells made from a patient's own cells, ALLO-715 is made from a healthy donor's cells, so it's ready to use off the shelf. The study also looked at adding a drug called nirogacestat to see if it could help the CAR T cells work better. The main goals were to check safety and find the right dose.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RELAPSED/REFRACTORY MULTIPLE MYELOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Banner MD Anderson Cancer Center

    Gilbert, Arizona, 85234, United States

  • City of Hope

    Duarte, California, 91010, United States

  • Cleveland Clinic Taussig Cancer Center

    Cleveland, Ohio, 44195, United States

  • Mayo Clinic

    Rochester, Minnesota, 55905, United States

  • Medical College of Wisconsin

    Milwaukee, Wisconsin, 53226, United States

  • Memorial Sloan Kettering Cancer Center

    New York, New York, 10065, United States

  • Sarah Cannon/Colorado Blood Cancer Institute

    Denver, Colorado, 80218, United States

  • St. David's South Austin Medical Center

    Austin, Texas, 78704, United States

  • Stanford Cancer Institute

    Palo Alto, California, 94305, United States

  • Texas Transplant Institute

    San Antonio, Texas, 78229, United States

  • Vanderbilt-Ingram Cancer Center

    Nashville, Tennessee, 37203, United States

Conditions

Explore the condition pages connected to this study.